Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
134 studies found for:    Open Studies | "Thyroid Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  BRAF V600E Mutations In Papillary Thyroid Carcinoma
Condition: Papillary Thyroid Carcinoma
Intervention: Genetic: BRAF V600E POSITIVITY
22 Recruiting Ponatinib for Advanced Medullary Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention: Drug: Ponatinib
23 Unknown  Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
Conditions: Thyroid Carcinoma;   Metastatic Sites Lung Bone Nodal
Intervention: Other: SPECT scan
24 Recruiting IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
Condition: Thyroid Cancer
Intervention: Radiation: I131 1.1 GBq
25 Recruiting Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study
Condition: Thyroid Cancer
Intervention:
26 Recruiting Study of External Beam Radiotherapy to Thyroid Carcinoma
Condition: Thyroid Cancer
Intervention: Radiation: External Beam Radiotherapy
27 Recruiting Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Drug: Vemurafenib (All Groups);   Drug: Vemurafenib (Post Surgery) - Group A + C;   Other: Post Surgery - Group B
28 Recruiting Efatutazone With Paclitaxel Versus Paclitaxel Alone in Treating Patients With Advanced Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Recurrent Thyroid Cancer
Interventions: Drug: efatutazone;   Drug: paclitaxel
29 Recruiting Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)
Condition: Thyroid Cancer
Intervention: Other: follow up visit
30 Unknown  Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: Recombinant thyrotropin
31 Not yet recruiting I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer
Condition: Differentiated Thyroid Carcinoma
Interventions: Radiation: Radioiodine I-131;   Radiation: I-124
32 Unknown  Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: pemetrexed + paclitaxel
33 Recruiting Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
Condition: Thyroid Cancer
Intervention: Drug: Sorafenib
34 Recruiting Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
Condition: Non-Medullary Thyroid Cancer
Intervention:
35 Unknown  Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma
Conditions: Thyroid Cancer;   Recurrence
Intervention:
36 Recruiting A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Intervention: Biological: GI-6207
37 Recruiting A Study of E7080 in Subjects With Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: E7080 capsule
38 Unknown  Diagnosing Thyroid Cancer Using a Blood Test
Condition: Differentiated Thyroid Cancer
Intervention:
39 Not yet recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Interventions: Drug: Cabozantinib (XL184) 140 mg;   Drug: Cabozantinib (XL184) lower dose;   Drug: Placebo tablet;   Drug: Placebo capsule
40 Recruiting The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Dietary Supplement: thymus honey mouthwash

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years